Anti-aging pill? singapore trial tests AKG on biological age
NCT ID NCT05706389
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking alpha-ketoglutarate (AKG), a natural substance in the body, can lower biological age in 120 middle-aged adults from Singapore. Participants must have a biological age older than their actual age. The study measures changes in DNA methylation (a marker of aging) and other health indicators over 6 months. It aims to see if aging can be slowed down with a simple supplement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * participants whose biological age (as measured by blood DNA methylation) is greater than their chronological age Exclusion Criteria: * pregnant women * more than ONE of the following chronic medical conditions (based on the medical history and during screening), they are NOT eligible to participate in the study: 1. Waist circumference more than or equal to 90 cm for males or more than or equal to 80 cm for females 2. Fasting triglycerides more than or equal to 1.7 mmol/l 3. High-density lipoprotein less than 1.0 mmol/l in men or less than 1.3 mmol/l in women 4. Blood pressure more than or equal to 130/85 mmHg or use of antihypertensive medication 5. Fasting glucose more than or equal to 6.0 mmol/l 6. Osteopenia 7. Mild Osteoarthritis not interfering in daily activities 8. Fatty liver * Participants will NOT be recruited if they fall in the following categories: 1. Pre-existing, or history of major CVD (coronary artery disease, heart failure, stroke, peripheral vascular disease, pulmonary hypertension), severe/uncontrolled hypertension (under 3 or more than 3 prescribed medications), rheumatic heart disease, congenital heart disease, deep vein thrombosis, pulmonary embolism 2. Type 1 diabetes and Type 2 diabetes under oral metformin or insulin therapy and with diabetic complications such as diabetic retinopathy, diabetic nephropathy 3. Active cancer or treatment of cancer in the last 3 years 4. Chronic obstructive pulmonary disease (COPD), severe asthma (taking daily medications) 5. Pregnant women will not be recruited into this study because of the safety issues associated with X-ray irradiation during DXA scan 6. Potential female participants who plan on pregnancy within the next 9 months of study period 7. Multiple sclerosis and autoimmune/immune deficiency diseases such as Rheumatic arthritis, HIV, Crohn's disease 8. Recent history of sepsis or infection (within 3 months of in-patient hospitalization) 9. Any psychiatric disease or neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease, Lewy body dementia, and any eating disorders 10. Any metal implants in the body 11. Hepatitis and Liver cirrhosis (independent of severity) 12. Severe kidney disease (GFR less than 30 ml/min/1.73 m2) 13. Skin disease (on oral or systemic medication for immune system) 14. Subjects receiving any other similar investigational product within 60 days or 5 halflives before the screening, whichever that is longer 15. Any serious medical illness which in the PI's judgment may jeopardize the subject by his or her participation in this study or may hamper his or her ability to perform and complete procedures required in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aging are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Healthy Longevity, Alexandra Hospital
Singapore, 159964, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sharing old memories boost mental Well-Being in old age?
- Can a Hands-On reflex therapy steady an older Person's stance?
- Scientists ask: when does a balance test score really improve?
- Gut check: can poop pills from young donors turn back the biological clock?
- Your smartwatch could soon warn you before you crash
- Can a tablet game rewire an aging brain to ignore distractions?